Efficacy of Mindfulness-Based Relapse Prevention

基于正念的复发预防的功效

• 批准号: 7268048
• 负责人: Gordon ALAN Marlatt
• 金额: $ 18.4万
• 依托单位: UNIVERSITY OF WASHINGTON
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-06-15 至 2009-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7268048
• 关键词: Abstinence; Adherence; Affect; Aftercare; Alcohols; Area; Behavioral; Caring; Clinical Trials; Cognitive; Cognitive Therapy; Communities; Competence; Condition; Control Groups; Control Locus; County; Data; Development; Disease; Drug Use Disorder; Drug abuse; Drug usage; Enrollment; Future; General Population; Individual; Intervention; Investigation; Literature; Manuals; Measures; Mediating; Mediator of activation protein; Meditation; Mental Depression; Mental disorders; Mission; Modeling; Outcome; Outpatients; Participant; Pattern; Pharmaceutical Preparations; Population; Prevention; Prevention intervention; Prevention program; Prevention strategy; Probability; Process; Randomized Clinical Trials; Rate; Recovery; Recruitment Activity; Relapse; Research; Research Design; Research Personnel; Risk; Role playing therapy; Sampling; Self Efficacy; Staging; Substance abuse problem; Techniques; Testing; Thinking; Training; Treatment Efficacy; Work; alcohol and other drug; base; comparison group; coping; craving; disorder later incidence prevention; drug relapse; efficacy trial; follow-up; improved; innovation; interest; mindfulness based cognitive therapy; prevent; programs; size; skills; treatment effect; treatment program; volunteer

DESCRIPTION (provided by applicant): The broad, long-term objective of the current research is to improve treatment for alcohol and other drug (AOD) use disorders through development of an innovative alternative approach to preventing AOD relapse. The specific aims of the research are 1) To develop a manual and therapist adherence/competence measures to standardize delivery of a Mindfulness-Based Relapse Prevention (MBRP) program for post-treatment relapse prevention of AOD problems, which will be patterned after Mindfulness-Based Cognitive Therapy for Depression (Segal, Teasdale & Williams, 2002) and incorporate cognitive-behavioral relapse prevention strategies (Daley & Marlatt, 1997); 2) To conduct a pilot randomized clinical trial to assess the feasibility of recruiting and retaining individuals for a large scale study and to determine effect size of MBRP in comparison to cognitive-behavioral group relapse prevention based on Marlatt's Relapse Prevention model (RP) alone (Daley & Marlatt, 1997). Both MBRP and RP conditions will be compared to a treatment as usual control group (TAU) in a sample of participants enrolled in continuing care following Intensive Outpatient Treatment, at baseline, post-treatment, 2-, and 4-months following the baseline assessment; and 3) Evaluate potential mediators of MBRP and RP treatment efficacy. We hypothesize that both MBRP and RP will be more efficacious than TAU. We hypothesize MBRP efficacy will be mediated by meta-cognitive processes, thought suppression, locus of control, skills to cope with urges and cravings, negative affect and meditation practice. We hypothesize RP efficacy will be mediated by self-efficacy, negative affect and coping abilities. This research builds on over 25 years of developing and implementing RP interventions. MBRP incorporates specific alcohol and drug-focused cognitive therapy techniques with an additional emphasis on mindfulness skills, and builds upon the Investigator's prior work on meditation-based interventions.

描述（由申请人提供）： 当前研究的广泛长期目标是通过开发一种创新的替代方法来预防AOD复发，改善对酒精和其他药物（AOD）使用障碍的治疗。 The specific aims of the research are 1) To develop a manual and therapist adherence/competence measures to standardize delivery of a Mindfulness-Based Relapse Prevention (MBRP) program for post-treatment relapse prevention of AOD problems, which will be patterned after Mindfulness-Based Cognitive Therapy for Depression (Segal, Teasdale & Williams, 2002) and incorporate cognitive-behavioral relapse prevention strategies (Daley &马拉特，1997年）； 2）进行一项飞行员随机临床试验，以评估招募和保留个体进行大规模研究的可行性，并确定MBRP的效果与基于Marlatt的复发预防模型（RP）相比，与认知行为行为群体的预防相比（Daley＆Marlatt，1997年）。在基线，治疗后，治疗后，2-和4个月后，在基线评估后，将MBRP和RP条件都与往常的对照组（TAU）进行比较。 3）评估MBRP和RP治疗功效的潜在介体。我们假设MBRP和RP都比Tau更有效。我们假设MBRP疗效将由元认知过程，思想抑制，控制源，以应对冲动和渴望，负面影响和冥想实践来介导。我们假设RP功效将由自我效能，负面影响和应对能力介导。这项研究以25年以上的发展和实施RP干预为基础。 MBRP结合了特定的酒精和注重药物的认知疗法技术，并额外强调正念技能，并基于研究者先前在基于冥想的干预措施方面的工作。

项目成果

Mindfulness-based relapse prevention for substance craving.

• DOI: 10.1016/j.addbeh.2012.04.001
• 发表时间: 2013-02
• 期刊: ADDICTIVE BEHAVIORS
• 影响因子: 4.4
• 作者: Witkiewitz, Katie;Bowen, Sarah;Douglas, Haley;Hsu, Sharon H.
• 通讯作者: Hsu, Sharon H.

Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: a randomized clinical trial.

• DOI: 10.1001/jamapsychiatry.2013.4546
• 发表时间: 2014-05
• 期刊: JAMA PSYCHIATRY
• 影响因子: 25.8
• 作者: Bowen, Sarah;Witkiewitz, Katie;Clifasefi, Seema L.;Grow, Joel;Chawla, Neharika;Hsu, Sharon H.;Carroll, Haley A.;Harrop, Erin;Collins, Susan E.;Lustyk, M. Kathleen;Larimer, Mary E.
• 通讯作者: Larimer, Mary E.

Depression, craving, and substance use following a randomized trial of mindfulness-based relapse prevention.

• DOI: 10.1037/a0019172
• 发表时间: 2010-06
• 期刊: JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY
• 影响因子: 5.9
• 作者: Witkiewitz, Katie;Bowen, Sarah
• 通讯作者: Bowen, Sarah

Mindfulness-based relapse prevention for substance use disorders: a pilot efficacy trial.

• DOI: 10.1080/08897070903250084
• 发表时间: 2009-10
• 期刊: Substance abuse
• 影响因子: 3.5
• 作者: Bowen S;Chawla N;Collins SE;Witkiewitz K;Hsu S;Grow J;Clifasefi S;Garner M;Douglass A;Larimer ME;Marlatt A
• 通讯作者: Marlatt A